OHDSI Digest – January 23rd, 2017

OHDSI MEETINGS THIS WEEK
Population-Level Estimation work group (Eastern Hemisphere) – Wednesday at 12pm ET
URL: https://meetings.webex.com/collabs/meetings/join?uuid=M6WE9AOKFETH2VEFPVCZWWBIT0-D1JL

Patient-level prediction WG meeting – Wednesday at 12pm ET
URL: https://global.gotomeeting.com/join/972917661
Join by phone:
United States: +1 (571) 317-3116
Netherlands: +31 (0) 208 084 055
Access Code: 972-917-661
Other country numbers can be found here: http://www.ohdsi.org/web/wiki/doku.php?id=projects:workgroups:patient-level_prediction

Architechture WG meeting – Thursday at 1pm ET
Webex: https://jjconferencing.webex.com/mw3000/mywebex/default.do?service=1&main_url=%2Fmc3000%2Fe.do%3Fsiteurl%3Djjconferencing%26AT%3DMI%26EventID%3D283835502%26MTID%3Dmb7e839a762fbdaab0608f27500679223%26Host%3DQUhTSwAAAAJ_RbVdkwLKAs2Z53zdqlJeWVp4xaaQjWtL7vrvJELJ3uGlhajeNGJ28I1CbKPYdpaOXXf6ejxpu0qTT0CRvAW60%26FrameSet%3D2&siteurl=jjconferencing&nomenu=true
Call-in toll-free number: 1-877-5659999 (US)
Call-in number: 1-617-9392838 (US)
Attendee access code: 498 480 37

ANNOUNCEMENTS
OHDSI F2F – Registration is now open for the OHDSI F2F to take place on March 17-18th at GeorgiaTech in Atlanta. Register here:
http://www.ohdsi.org/events/2017-ohdsi-collaborator-face-to-face/

COMMUNITY PUBLICATIONS
Drug Repurposing Hypothesis Generation Using the “RE:fine Drugs” System.
https://www.ncbi.nlm.nih.gov/pubmed/28060329

Incretin-based therapy and acute cholecystitis: a review of case reports and EudraVigilance spontaneous adverse drug reaction reporting database.
https://www.ncbi.nlm.nih.gov/pubmed/26936090

Prediction of black box warning by mining patterns of Convergent Focus Shift in clinical trial study populations using linked public data.
https://www.ncbi.nlm.nih.gov/pubmed/26851401

Multivariate analysis of the population representativeness of related clinical studies.
https://www.ncbi.nlm.nih.gov/pubmed/26820188

Engaging hospitalized patients in clinical care: Study protocol for a pragmatic randomized controlled trial.
https://www.ncbi.nlm.nih.gov/pubmed/26795675

Posted in Uncategorized